Press Releases
RADNOR, Pa., Dec. 22, 2021 /PRNewswire/ -- In a press release issued under the same headline on December 14, 2021, by Avantor, Inc. (NYSE: AVTR), please note that the presentation time has been updated now that the conference has moved to a virtual format. The correct presentation time is 9:45 a.m. Eastern Time / 6:45 a.m. Pacific Time. All other information remains the same.
The corrected release appears below:
Avantor® to Participate in the 40th Annual J.P. Morgan Healthcare Conference
RADNOR, Pa. (USA) – Dec. 22, 2021 – Avantor, Inc. (NYSE: AVTR), a leading global provider of mission-critical products and services to customers in the life sciences, advanced technologies and applied materials industries, will participate in the 40th Annual J.P. Morgan Healthcare Conference, now being held virtually, on Monday, January 10, 2022. Michael Stubblefield, President and CEO, will provide an update on the Company and its priorities in the segment beginning at approximately 9:45 a.m. Eastern Time.
A live webcast can be accessed on the investors section of our website and a replay will be available through February 10, 2022.
About Avantor
Avantor®, a Fortune 500 company, is a leading global provider of mission-critical products and services to customers in the biopharma, healthcare, education & government, and advanced technologies & applied materials industries. Our portfolio is used in virtually every stage of the most important research, development and production activities in the industries we serve. Our global footprint enables us to serve more than 225,000 customer locations and gives us extensive access to research laboratories and scientists in more than 180 countries. We set science in motion to create a better world. For more information, please visit www.avantorsciences.com.
Media Contact
Allison Hosak
Senior Vice President, Global Communications and Brand
Avantor
908-329-7281
Allison.Hosak@avantorsciences.com
Investor Relations Contact
Tommy Thomas
Vice President, Investor Relations
Avantor
781-375-8051
Tommy.Thomas@avantorsciences.com
SOURCE Avantor and Financial News
